E Clinical Solution Market

Global Market Study on E-Clinical Solution Software: Blooming Clinical Trial Industry in China and India boosting the Overall Market Growth in Asia

E-Clinical Solution Software Market Segmented By Web-based, Licensed Enterprise, Cloud-based Mode of Delivery with Clinical Data Management, Clinical Trial Management System, Electronic Clinical Outcome Assessment Solution, Randomization and Trial Supply Management, Safety Solution Product

  • May-2015
  • PMRREP2884
  • 124 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

Table of Content

 

Chapter 1 Preface 12

1.1 Report Description 12

1.2 Research Methodology 13

1.3 Assumptions 13

 

Chapter 2 Market Synopsis 14

 

Chapter 3 Porter’s Five Forces Analysis 16

3.1 Bargaining Power of Suppliers 16

3.2 Bargaining Power of Buyers 17

3.3 Threat of New Entrants 17

3.4 Threat of Substitutes 17

3.5 Intensity of Rivalry 17

 

Chapter 4 Industry Overview 18

4.1 Market Definition 18

4.2 Market Drivers 20

     4.2.1 Increasing number of clinical trials 21

     4.2.2 Rising spending on clinical research and development in the pharmaceutical industry 22

     4.2.3 Growing clinical trial outsourcing 23

     4.2.4 Rising need for improved data standardization and reducing the time consumed during clinical trial process 23

4.3 Impact Analysis of Market Drivers 24

4.4 Market Restraints 25

     4.4.1 High costs of implementation and lack of skilled manpower 25

     4.4.2 Lack of high-speed broadband facilities and IT professionals in remote areas 25

     4.4.3 Long approval times for clinical trials 26

4.5 Impact Analysis of Market Restraints 27

4.6 Market Trends 27

     4.6.1 Rising number of collaborations and partnerships 27

     4.6.2 Increasing number of mergers and acquisitions 28

 

Chapter 5 Global Market Size and Forecast 30

 

Chapter 6 Market Size and Forecast by Mode of Delivery 38

6.1 Web-based e-clinical solution software 38

6.2 Licensed Enterprise e-clinical solution software 40

6.3 Cloud-based e-clinical solution software 42

 

Chapter 7 Market Size and Forecast by Product 45

7.1 Clinical Data Management 45

7.2 Clinical Trial Management System 47

7.3 Electronic Clinical Outcome Assessment Solution 49

7.4 Randomization and Trial Supply Management 51

7.5 Safety Solution 53

 

Chapter 8 Market Size and Forecast by End User 56

8.1 Pharmaceutical 56

8.2 Clinical Research Organization 58

8.3 Healthcare Providers 60

 

Chapter 9 Market Size and Forecast by Geography 63

9.1 North America 63

     9.1.1 U.S. 65

9.2 Europe 68

     9.2.1 Germany 71

     9.2.2 France 74

     9.2.3 Poland 78

9.3 Asia 81

     9.3.1 China 85

     9.3.2 South Korea 88

9.4 Rest of the World 92

 

Chapter 10 Competitive Scenario 93

10.1 Competitive Benchmarking 93

 

Chapter 11 Company Profiles 95

11.1 Oracle Corporation 95

     11.1.1 Company Overview 95

     11.1.2 Products and Services 95

     11.1.3 Financial Performance 96

     11.1.4 Recent Developments 96

11.2 Merge Healthcare Incorporated 98

     11.2.1 Company Overview 98

     11.2.2 Products and Services 98

     11.2.3 Financial Performance 99

     11.2.4 Recent Developments 99

11.3 Medidata Solutions Inc. 101

     11.3.1 Company Overview 101

     11.3.2 Products and Services 101

     11.3.3 Financial Performance 102

     11.3.4 Recent Developments 102

11.4 PAREXEL International Corporation 105

     11.4.1 Company Overview 105

     11.4.2 Products and Services 105

     11.4.3 Financial Performance 105

     11.4.4 Recent Developments 106

11.5 BioClinica 107

     11.5.1 Company Overview 107

     11.5.2 Products and Services 107

     11.5.3 Financial Performance 107

     11.5.4 Recent Developments 108

11.6 ERT 110

     11.6.1 Company Overview 110

     11.6.2 Products and Services 110

     11.6.3 Financial Performance 110

     11.6.4 Recent Developments 111

11.7 OmniComm Systems Inc. 112

     11.7.1 Company Overview 112

     11.7.2 Products and Services 112

     11.7.3 Financial Performance 112

     11.7.4 Recent Developments 113

11.8 PHT Corporation 116

     11.8.1 Company Overview 116

     11.8.2 Products and Services 116

     11.8.3 Financial Performance 116

     11.8.4 Recent Developments 117

11.9 DATATRAK International Inc. 118

     11.9.1 Company Overview 118

     11.9.2 Products and Services 118

     11.9.3 Financial Performance 119

     11.9.4 Recent Developments 119

11.10 CRF Health Inc. 121

     11.10.1 Company Overview 121

     11.10.2 Products and Services 121

     11.10.3 Financial Performance 121

     11.10.4 Recent Developments 122

Find Out More about the Report Coverage

List of Tables

List of Tables

TABLE 1: Market Snapshot: E-clinical Solution Software Market (2014 & 2020) 14

TABLE 2: Clinical trials conducted in different countries by December 2011 and May 2014 21

TABLE 3: R&D investment in pharmaceutical industry, by country (US$ Mn) in 2010 and 2011  22

TABLE 4: Drivers for e-clinical solution software market: Impact analysis 24

TABLE 5: Estimated average timelines for clinical trial approval in various countries 26

TABLE 6: Restraints for e-clinical solution software market: Impact analysis 27

TABLE 7: Major major collaborations and partnerships by e-clinical solution software companies (January 2011-May 2014) 28

TABLE 8: Major major mergers and acquisitions in e-clinical solution software market (January 2011- May 2014) 29

TABLE 9: Global e-clinical solution software market size by region, 2009–2013 (US$ Mn) 31

TABLE 10: Global e-clinical solution software market size by region, 2014–2020 (US$ Mn) 31

TABLE 11: Global e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 32

TABLE 12: Global e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 33

TABLE 13: Global e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 34

TABLE 14: Global e-clinical solution software market size by end user 2014–2020 (US$ Mn) 35

TABLE 15: Global e-clinical solution software market size by product, 2009–2013 (US$ Mn) 36

TABLE 16: Global e-clinical solution software market size by product, 2014–2020 (US$ Mn) 36

TABLE 17: Web-based e-clinical solution software market size by region, 2009–2013 (US$ Mn) 39

TABLE 18: Web-based e-clinical solution software market size by region, 2014–2020 (US$ Mn) 39

TABLE 19: Licensed Enterprise e-clinical solution software market size by region, 2009–2013 (US$ Mn) 41

TABLE 20: Licensed Enterprise e-clinical solution software market size by region, 2014–2020 (US$ Mn) 41

TABLE 21: Cloud based e-clinical solution software market size by region, 2009–2013 (US$ Mn) 43

TABLE 22: Cloud-based e-clinical software solution market size by region, 2014–2020 (US$ Mn) 43

TABLE 23: Clinical data management in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 46

TABLE 24: Clinical data management in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 46

TABLE 25: Clinical trial management system in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 48

TABLE 26: Clinical trial management system in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 48

TABLE 27: Electronic clinical outcome assessment solution in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 50

TABLE 28: Electronic clinical outcome assessment solution in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 51

TABLE 29: Randomization and trial supply management in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 52

TABLE 30: Randomization and trial supply management in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 53

TABLE 31: Safety solution in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 54

TABLE 32: Safety solution in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 55

TABLE 33: Pharmaceutical industry in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 57

TABLE 34: Pharmaceutical industry in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 57

TABLE 35: Clinical research organization in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 59

TABLE 36: Clinical research organization in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 59

TABLE 37: Healthcare providers in e-clinical solution software market size by region, 2009–2013 (US$ Mn) 61

TABLE 38: Healthcare providers in e-clinical solution software market size by region, 2014–2020 (US$ Mn) 61

TABLE 39: North America e-clinical solution software market size by region, 2009–2013 (US$ Mn) 64

TABLE 40: North America e-clinical solution software market size by region, 2014–2020 (US$ Mn) 64

TABLE 41: U.S. e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 65

TABLE 42: U.S. e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 66

TABLE 43: U.S. e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 67

TABLE 44: U.S. e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 68

TABLE 45: Europe e-clinical solution software market size by region, 2009–2013 (US$ Mn) 69

TABLE 46: Europe e-clinical solution software market size by region, 2014–2020 (US$ Mn) 70

TABLE 47: Germany e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 72

TABLE 48: Germany e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 72

TABLE 49: Germany e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 73

TABLE 50: Germany e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 74

TABLE 51: France e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 75

TABLE 52: France e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 76

TABLE 53: France e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 77

TABLE 54: France e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 77

TABLE 55: Poland e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 78

TABLE 56: Poland e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 79

TABLE 57: Poland e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 80

TABLE 58: Poland e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 81

TABLE 59: Asia e-clinical solution software market size by region, 2009–2013 (US$ Mn) 83

TABLE 60: Asia e-clinical solution software market size by region, 2014–2020 (US$ Mn) 83

TABLE 61: China e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 86

TABLE 62: China e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 86

TABLE 63: China e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 87

TABLE 64: China e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 88

TABLE 65: South Korea e-clinical solution software market size by mode of delivery, 2009–2013 (US$ Mn) 89

TABLE 66: South Korea e-clinical solution software market size by mode of delivery, 2014–2020 (US$ Mn) 90

TABLE 67: South Korea e-clinical solution software market size by end user, 2009–2013 (US$ Mn) 91

TABLE 68: South Korea e-clinical solution software market size by end user, 2014–2020 (US$ Mn) 91

TABLE 69: MajorMajor Oracle Corporation categories and products 95

TABLE 70: Major Merge Healthcare categories and products 98

TABLE 71: Major Medidata Solutions products and applications 101

TABLE 72: Major PAREXEL International Corporation categories, products and services 105

TABLE 73: Major BioClinica categories and products 107

TABLE 74: Major ERT categories and products 110

TABLE 75: Major OmniComm Systems products and application 112

TABLE 76: Major PHT Corporation categories and products 116

TABLE 77: Major DATATRAK International products 118

TABLE 78: Major CRF Health categories, products and services 121

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

FIG. 1: E-clinical solution software market: Porter’s five forces analysis 16

FIG. 2: Major major technologies in e-clinical solution software 19

FIG. 3: Total e-clinical solution 20

FIG. 4: Global e-clinical solution software market by region, 2013 (% share) 30

FIG. 5: Global e-clinical solution software market, by mode of delivery 2013 (% share) 32

FIG. 6: Global e-clinical solution software market, by end user 2013 (% share) 34

FIG. 7: Global e-clinical solution software market, by product 2013 (% share) 35

FIG. 8: Web based e-clinical solution software market, by region 2013 (% share) 38

FIG. 9: Global e-clinical solution software market, by region 2013 (% share) 40

FIG. 10: Global e-clinical software solution market, by region 2013 (% share) 42

FIG. 11: Clinical data management in e-clinical solution software market, by region, 2013 (% share) 45

FIG. 12: Clinical trial management system in e-clinical solution software market, by region, 2013 (% share) 47

FIG. 13: Electronic clinical outcome assessment solution in e-clinical solution software market, by region, 2013 (% share) 50

FIG. 14: Randomization and trial supply management in e-clinical solution software market, by region, 2013 (% share) 52

FIG. 15: Safety solution in e-clinical solution software market, by region, 2013 (% share) 54

FIG. 16: Pharmaceutical industry in e-clinical solution software market, by region, 2013 (% share) 56

FIG. 17: Clinical research organization in e-clinical solution software market, by region, 2013 (% share) 58

FIG. 18: Healthcare providers in e-clinical solution software market, by region, 2013 (% share) 60

FIG. 19: North America e-clinical solution software market, by region, 2013 (% share) 63

FIG. 20: U.S. e-clinical solution software market, by mode of delivery, 2013 (% share) 65

FIG. 21: U.S. e-clinical solution software market, by end user, 2013 (% share) 67

FIG. 22: Europe e-clinical solution software market, by region, 2013 (% share) 69

FIG. 23: Germanyy e-clinical solution software market, by mode of delivery, 2013 (% share) 71

FIG. 24: Germanyy e-clinical solution software market, by end user, 2013 (% share) 73

FIG. 25: France e-clinical solution software market, by mode of delivery, 2013 (% share) 75

FIG. 26: France e-clinical solution software market, by end user, 2013 (% share) 76

FIG. 27: Poland e-clinical solution software market, by mode of delivery, 2013 (% share) 78

FIG. 28: Poland e-clinical solution software market, by end user, 2013 (% share) 80

FIG. 29: Asia e-clinical solution software market, by region, 2013 (% share) 82

FIG. 30: China e-clinical solution software market, by mode of delivery, 2013 (% share) 85

FIG. 31: China e-clinical solution software market, by end user, 2013 (% share) 87

FIG. 32: South Korea e-clinical solution software market, by mode of delivery, 2013 (% share) 89

FIG. 33: South Korea e-clinical solution software market, by end user, 2013 (% share) 90

FIG. 34: Competitive benchmarking 93

FIG. 35: Oracle Corporation total revenue and net income 2011–2013 (US$ Mn) 96

FIG. 36: Merge Healthcare net sales and net income 2011–2013 (US$ Mn) 99

FIG. 37: Medidata Solutions total revenue and net income 2011–2013 (US$ Mn) 102

FIG. 38: PAREXEL International Corporation total service revenue and net income 2011–2013 (US$ Mn) 106

FIG. 39: BioClinica total revenue and net income 2010-2012 (US$ Mn) 108

FIG. 40: OmniComm Systems total revenue and net income 2011–2013 (US$ Mn) 113

FIG. 41: DATATRAK International revenue and net income 2011–2013 (US$ Mn) 119

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Persistence Market Research (PMR) provides key insights on the global e-clinical solution software market over the forecast period (2014-2020). The primary objective of the report is to provide in-depth analysis and future market estimations, including growth drivers, restraints, opportunities, trends, key segments, status of the regional markets and key market players operating in the global home infusion therapy devices market. Along with the provision of quality insights, quantification of data has been considered through discussions with, health experts, marketing managers and clinicians.   

To understand and assess opportunities in the global market, the report is categorically split into four sections in terms of market value (US$ Mn), namely market analysis by product, by mode of delivery, by end user, and by geography. The report further provides comprehensive data on global market estimations, competitive landscape and forecast values. The aforementioned segments have been analyzed in terms of Basis Point (BPS) to understand each segment’s relative contribution to the overall market growth. 

The geographical analysis studies the market on the basis of the regional opportunities and estimates the market value for each region during the forecast period. The report also considers a year-on-year growth based on regional market analysis, in order to identify right opportunities in each of the regions and to understand predictability of the market.

The last part of the report provides an exhaustive analysis on the global competitive landscape including leading market participants and a dashboard view. Market strategies of prominent players and their key developments are also included in the report. 

Research Methodology

To deduce the global e-clinical solution software market, the report considers various aspects based on secondary research. Furthermore, key data points such as region-wise split by product, by mode of delivery, by end user and qualitative inputs from primary respondents have been incorporated to arrive at appropriate market estimates. The forecast presented in the report assesses the total revenue generated and expected revenue contribution in the global e-clinical solution software market.   

The report begins with sizing the market in terms of value and volume for the base year, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, gathered data is triangulated via different analysis based on the supply side and demand side drivers and other key dynamics of the global e-clinical solution software market. To develop the market forecast, Persistence Market Research has also conducted a factor analysis to understand the impact of various forces/factors on the target market. The report provides forecasts not only in terms of CAGR but also presents a detailed analysis based on key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities.    

Another key feature of this report is an analysis of the global e-clinical solution software market and the corresponding revenue forecast in terms of absolute dollar opportunity, usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global e-clinical solution software market. Further, to understand key segments in terms of their growth and overall global e-clinical solution software market performance, Persistence Market Research has developed a market attractiveness index to help providers identify existing market opportunities in the global e-clinical solution software market.

Recommendations

Isoparaffin Solvents Market

The incremental $ opportunity created by the market during the forecast period is pegged at nearly US$ 51.9 Mn. The isoparaffin solvents market is expected to expand at a CAGR of 3.7% during the forecast period..

EMEA Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

Our Clients

Our Clients